| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/18/2009 | EP2036926A2 Single-chain, multiple antigen forming molecule, its manufacture and use |
| 03/18/2009 | EP2036574A1 Medicinal agent for treating fatness, diabetes, and diseases associated with impaired glucose tolerance |
| 03/18/2009 | EP2036573A1 HLA binding peptides and their uses |
| 03/18/2009 | EP2035585A2 Methods for regulating complement cascade proteins using astrovirus coat protein and derivatives thereof |
| 03/18/2009 | EP2035457A2 Vaccine carrier |
| 03/18/2009 | EP2035448A2 Neuroactive fragments of app |
| 03/18/2009 | EP2035039A2 Extending survival of cancer patients with elevated levels of egf or tgf-alpha |
| 03/18/2009 | EP2035038A2 Compositions and methods for treating polycystic kidney disease |
| 03/18/2009 | EP2035037A2 Methods, compositions, and kits for treating shiga toxin associated conditions |
| 03/18/2009 | EP2035036A2 Live bacterial vaccine |
| 03/18/2009 | EP2035035A2 Immunogenic compositions for streptococcus agalactiae |
| 03/18/2009 | EP2035034A2 Glycosylation engineered antibody therapy |
| 03/18/2009 | EP2035033A1 Pharmaceutical composition for the sublingual administration of vaccines, method for the preparation of the same and uses thereof |
| 03/18/2009 | EP2034830A1 Methods of treating stroke |
| 03/18/2009 | EP1613350B1 Therapy of autoimmune disease in a patient with an inadequate response to a tnf-alpha inhibitor |
| 03/18/2009 | EP1399482B1 Determination of bone-sialoprotein in bodily fluids for oncological problems |
| 03/18/2009 | EP1283887B1 Chimeric arterivirus-like particles |
| 03/18/2009 | EP1146789B1 Treating cancers associated with overexpression of her-2/neu |
| 03/18/2009 | EP1068522B1 Helicobacter pylori nap protein |
| 03/18/2009 | EP1021725B1 Early detection of lysosomal storage disorders |
| 03/18/2009 | EP0814834B2 Non-toxic immunogens derived from a retroviral regulatory protein, antibodies directed against said immunogens, preparation method therefor, and pharmaceutical compositions containing the same |
| 03/18/2009 | EP0732937B2 Non-toxic mucosal adjuvant |
| 03/18/2009 | CN101389756A Monoclonal antibody, gene encoding the antibody, hybridoma, pharmaceutical composition, and diagnostic reagent |
| 03/18/2009 | CN101389658A Cytotoxicity mediation of cells evidencing surface expression of cd59 |
| 03/18/2009 | CN101389657A Thymic stromal lymphopoietin (TSLP) antibodies and uses thereof |
| 03/18/2009 | CN101389656A Anti-periostin antibody and pharmaceutical composition for preventing or treating periostin-related disease containing the same |
| 03/18/2009 | CN101389351A Human anti-il-23 antibodies, compositions, methods and uses |
| 03/18/2009 | CN101389350A Multivalent pcv2 immunogenic compositions and methods of producing such compositions |
| 03/18/2009 | CN101389349A Educated nkt cells and their uses in the treatment of immune-related disorders |
| 03/18/2009 | CN101387646A Complement pathway inhibitors binding to c5 and c5a without preventing formation of c5b |
| 03/18/2009 | CN101386849A Nematode epidermal protein for anti-insect blood cell immunity and gene order |
| 03/18/2009 | CN101386833A Recombinant bacterium of brucella abortus and use thereof |
| 03/18/2009 | CN101386832A Recombinant bacterium of brucella melitensis and use thereof |
| 03/18/2009 | CN101386831A Recombinant bacterium of brucella abortus with immunity labeling and use thereof |
| 03/18/2009 | CN101386830A Recombinant bacterium of brucella melitensis with immunity labeling and use thereof |
| 03/18/2009 | CN101386651A Expression and export of angiostatin and endostatin as immunofusis |
| 03/18/2009 | CN101386649A High-stable anti-helicobacter pylori recombinant VacA specific egg yolk antibody and use thereof |
| 03/18/2009 | CN101386648A Neutralizing monoclonal antibodies against B type botulinum neurotoxin, preparation method and use thereof |
| 03/18/2009 | CN101386643A Expression of vibrio alginolyticus outer membrane protein VA0760 and application thereof as vaccine component |
| 03/18/2009 | CN101386642A Expression of vibrio alginolyticus outer membrane protein VA0760 and application thereof as vaccine component |
| 03/18/2009 | CN101386641A Synthetic peptide vaccines for foot-and-mouth disease |
| 03/18/2009 | CN101385855A Fine purification method of polyvalent anti-snake venom freeze-dry blood serum |
| 03/18/2009 | CN101385854A Rabbit hemorrhagic disease vaccine and antigens |
| 03/18/2009 | CN101385853A Preparation of domestic adsorhed diphtheria tetanus and acellular pertussis combined vaccine without formaldehyde and merthiolate |
| 03/18/2009 | CN100469882C Preparation and use of conservative region of recombinant helicobacter pylori adhesin |
| 03/18/2009 | CN100469793C Anti-osteopontin antibody and use thereof |
| 03/18/2009 | CN100469792C Regulation of lipid levels via the Zmaxl or HBM gene |
| 03/18/2009 | CN100469789C Variants of allergenic proteins of the Group2 of dermatophagoides |
| 03/17/2009 | US7504560 transgenic edible plants comprising a nucleotide construct, including promoters that preferentially targets expression to an edible tissue of the plant and untranslated signal sequences, that codes an immunogen of a recombinant animal viral antigen protein, that induces an immune responses |
| 03/17/2009 | US7504485 Immunoglobulin for use in diagnosis, treatment and prevention of arthritic, nervous system, autoimmune and kidney disorders |
| 03/17/2009 | US7504483 α-β C4BP-type recombinant heteromultimeric proteins |
| 03/17/2009 | US7504481 TRP channel family member, LTRPC3 polypeptides |
| 03/17/2009 | US7504479 Use of immunogenic immunosuppressive and/or angiogenic proteins which have been rendered inactive, process for their preparation and pharmaceutical or vaccinal uses |
| 03/17/2009 | US7504255 Virally infected cells for use as models in screening modulators/treatments of liver disorders; viricides |
| 03/17/2009 | US7504254 Hybridomas; monoclonal antibodies do not cross-react with host tissue polysialic acid and pose minimal risk of autoimmune activity; vaccines; mimetics |
| 03/17/2009 | US7504246 Hyaluronan synthase gene and uses thereof |
| 03/17/2009 | US7504232 Identifying immunomodulators for diagnosis and treatment of inflammatory, granulomatous, fibrosis, multiple sclerosis, bacterial or viral diseases |
| 03/17/2009 | US7504228 Integrin linked kinase modulation of monocyte activation |
| 03/17/2009 | US7504226 Obtaining an inhibitor of antibody-mediated lipid oxidation; drug screening; hemolysis; anticholesterol agents; cardiovascular disorder therapy |
| 03/17/2009 | US7504224 Which comprises three N-helices and at least two, but not three, of the three C-helices of the trimer-of-hairpin structure of HIV gp41; inhibits infection of cells; drug screening; gene therapy |
| 03/17/2009 | US7504212 Cancer monitoring and therapeutics |
| 03/17/2009 | US7504206 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs |
| 03/17/2009 | US7504205 Uncharacterized ORF3 in SARS-coronavirus is a cyclic-AMP-dependent kinase and a target for SARS therapy |
| 03/17/2009 | US7504111 Protein from gonococcus (Neisseria gonorrhoeae), including a specific amino acid sequence; antigens for vaccines, immunogenic compositions, and/or diagnostics; useful for distinguishing between gonococcus and meningococcus |
| 03/17/2009 | US7504110 Protein-based Streptococcus pneumoniae vaccines |
| 03/17/2009 | US7504109 Avian pandemic; immunogens; antibodies; immunology |
| 03/17/2009 | US7504108 Polypeptides; immunogenic compositions; generating immune responses; kits |
| 03/17/2009 | US7504107 pretreatment step involving a highly specific and high affinity neutralizing antibody |
| 03/17/2009 | US7504106 Method and composition for treatment of renal failure with antibodies and their equivalents as partial or complete replacement for dialysis |
| 03/17/2009 | US7504105 Antibody for diagnosising immunology disorders |
| 03/17/2009 | US7504104 Monoclonal antibodies which preferentially bind to chemokine receptors, used for immunotherapy, as antiinflammatory, aniticarcinogenic agents and for prophylaxis of respiratory system disorders or antiallergens |
| 03/17/2009 | US7504103 Targetting slow-growing, relatively mutationally-spared cancer; one-step genetic switches; antiproliferative agents; magnetic resonance imaging |
| 03/17/2009 | US7504102 Therapeutic mixture comprising immunoglobulin specific to vitronectin receptor for use in diagnosis, prevention and treatment of restenosis |
| 03/17/2009 | US7504101 Methods for enhancing antigen-specific immune response using antibodies that bind OX-40 |
| 03/17/2009 | US7504095 2,10-dioxo,2,12,12-trihydroxy,8-amino-4,4a,5a,6,9,10,11,11a,12,12a-decahydropterino(6',7':5,6)pyrano(2,3-d)-1,3,2-dioxaphosphorin |
| 03/17/2009 | CA2262546C Lo-cd2a antibody and uses thereof for inhibiting t cell activation and proliferation |
| 03/17/2009 | CA2208860C Polymeric vaccine adjuvants |
| 03/17/2009 | CA2171434C Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 03/13/2009 | CA2597878A1 Capsid protein and use therefore |
| 03/12/2009 | WO2009033176A1 A method of targeting a transferrin receptor |
| 03/12/2009 | WO2009033121A2 Molecules and methods for treatment and detection of diabetes |
| 03/12/2009 | WO2009033095A2 Humanized pai-1 antibodies |
| 03/12/2009 | WO2009033094A2 Antibodies and related molecules that bind to 24p4c12 proteins |
| 03/12/2009 | WO2009033074A2 De-duplication in virtualized server and virtualized storage environments |
| 03/12/2009 | WO2009033009A2 Antibodies against flagellin and uses thereof |
| 03/12/2009 | WO2009032978A2 Compositions and methods for diagnosing and treating urinary tract infections |
| 03/12/2009 | WO2009032949A2 High affinity anti-prostate stem cell antigen (psca) antibodies for cancer targeting and detection |
| 03/12/2009 | WO2009032913A2 Thermal inactivation of rotavirus |
| 03/12/2009 | WO2009032782A2 Compositions that bind multiple epitopes of igf-1r |
| 03/12/2009 | WO2009032661A1 Humanized anti-cxcr5 antibodies, derivatives thereof and their uses |
| 03/12/2009 | WO2009032256A2 Apc activators in combination with a cytokine-secreting cell and methods of use thereof |
| 03/12/2009 | WO2009032224A2 Compositions and methods for inhibiting squamous cell carcinoma |
| 03/12/2009 | WO2009032145A1 Anti-igf-1r antibodies and uses thereof |
| 03/12/2009 | WO2009031230A1 Anti-cd20 monoclonal antibodies |
| 03/12/2009 | WO2009031151A2 Antibodies and methods for diagnosing and treating cancer |
| 03/12/2009 | WO2009030998A1 Pyrimidine compounds as toll-like receptor (tlr) agonists |
| 03/12/2009 | WO2009030996A1 Triazole compounds as toll-like receptor (tlr) agonists |
| 03/12/2009 | WO2009030978A2 Conformers of bacterial adhesins |
| 03/12/2009 | WO2009030931A1 Compound for controlling appetite |
| 03/12/2009 | WO2009030872A1 Materials and methods for the treatment of hepatitis c |